{
 "schema_version": 1,
 "id": "4530-20260107",
 "type": "MBO",
 "status": "completed",
 "announced_date": "2026-01-07",
 "target": {
  "edinet_code": "E00944",
  "sec_code": "4530",
  "name": "久光製薬株式会社",
  "name_en": "HISAMITSU PHARMACEUTICAL CO.,INC.",
  "industry": "医薬品",
  "industry_en": "Pharmaceutical"
 },
 "acquirer": {
  "edinet_code": "E41321",
  "sec_code": null,
  "name": "タイヨー興産株式会社",
  "name_en": "Taiyo Kosan Co., Ltd.",
  "industry": "内国法人・組合（有価証券報告書等の提出義務者以外）",
  "industry_en": null
 },
 "anchor_doc_id": "S100XEKS",
 "needs_review": false,
 "review_reason": null,
 "terms": {
  "tender_price": {
   "history": [
    {
     "value": 6082,
     "unit": "yen",
     "as_of_date": null,
     "source": {
      "doc_id": "S100XEKS",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
      "submitted": "2026-01-07",
      "quote": "本公開買付価格6,082円は、本公開買付けの実施についての公表日の前営業日である2026年１月５日の対象者株式の東京証券取引所プライム市場における終値4,500円に対して35.16％"
     }
    }
   ],
   "latest": {
    "value": 6082,
    "unit": "yen",
    "as_of_date": null,
    "source": {
     "doc_id": "S100XEKS",
     "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
     "submitted": "2026-01-07",
     "quote": "本公開買付価格6,082円は、本公開買付けの実施についての公表日の前営業日である2026年１月５日の対象者株式の東京証券取引所プライム市場における終値4,500円に対して35.16％"
    }
   }
  },
  "min_shares": {
   "history": [
    {
     "value": 41119400,
     "unit": "shares",
     "as_of_date": null,
     "source": {
      "doc_id": "S100XEKS",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
      "submitted": "2026-01-07",
      "quote": "本公開買付けにおいては、買付予定数の下限を41,119,400株(所有割合：58.33％)に設定しており"
     }
    }
   ],
   "latest": {
    "value": 41119400,
    "unit": "shares",
    "as_of_date": null,
    "source": {
     "doc_id": "S100XEKS",
     "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
     "submitted": "2026-01-07",
     "quote": "本公開買付けにおいては、買付予定数の下限を41,119,400株(所有割合：58.33％)に設定しており"
    }
   }
  },
  "is_mbo": {
   "history": [
    {
     "value": "該当",
     "unit": "text",
     "as_of_date": null,
     "source": {
      "doc_id": "S100XEKS",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
      "submitted": "2026-01-07",
      "quote": "本取引は、いわゆるマネジメント・バイアウト(ＭＢＯ)(注４)に該当し"
     }
    }
   ],
   "latest": {
    "value": "該当",
    "unit": "text",
    "as_of_date": null,
    "source": {
     "doc_id": "S100XEKS",
     "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf",
     "submitted": "2026-01-07",
     "quote": "本取引は、いわゆるマネジメント・バイアウト(ＭＢＯ)(注４)に該当し"
    }
   }
  },
  "tendered_shares": {
   "history": [
    {
     "value": 41803599,
     "unit": "shares",
     "as_of_date": null,
     "source": {
      "doc_id": "S100XMO3",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XMO3.pdf",
      "submitted": "2026-02-20",
      "quote": "応募株券等の総数(41,803,599株)"
     }
    }
   ],
   "latest": {
    "value": 41803599,
    "unit": "shares",
    "as_of_date": null,
    "source": {
     "doc_id": "S100XMO3",
     "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XMO3.pdf",
     "submitted": "2026-02-20",
     "quote": "応募株券等の総数(41,803,599株)"
    }
   }
  },
  "result": {
   "history": [
    {
     "value": "成立",
     "unit": "text",
     "as_of_date": null,
     "source": {
      "doc_id": "S100XMO3",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XMO3.pdf",
      "submitted": "2026-02-20",
      "quote": "応募株券等の総数(41,803,599株)が買付予定数の下限(41,119,400株)以上となりましたので、公開買付開始公告(その後公表により訂正された事項を含みます。)及び公開買付届出書(その後提出された公開買付届出書の訂正届出書により訂正された事項を含みます。)に記載のとおり、応募株券等の全部の買付け等を行います。"
     }
    }
   ],
   "latest": {
    "value": "成立",
    "unit": "text",
    "as_of_date": null,
    "source": {
     "doc_id": "S100XMO3",
     "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XMO3.pdf",
     "submitted": "2026-02-20",
     "quote": "応募株券等の総数(41,803,599株)が買付予定数の下限(41,119,400株)以上となりましたので、公開買付開始公告(その後公表により訂正された事項を含みます。)及び公開買付届出書(その後提出された公開買付届出書の訂正届出書により訂正された事項を含みます。)に記載のとおり、応募株券等の全部の買付け等を行います。"
    }
   }
  }
 },
 "premiums": [
  {
   "value": 35.16,
   "unit": "percent",
   "as_of_date": "2026-01-05",
   "source": {
    "doc_id": "S100XELY",
    "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
    "submitted": "2026-01-07",
    "quote": "2026年１月５日)の東京証券取引所プライム市場における当社株式の終値4,500円に対して35.16％"
   },
   "basis": "前営業日終値",
   "basis_en": "Closing price on the business day before announcement"
  },
  {
   "value": 41.94,
   "unit": "percent",
   "as_of_date": "2026-01-05",
   "source": {
    "doc_id": "S100XELY",
    "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
    "submitted": "2026-01-07",
    "quote": "同日までの過去１ヶ月間の終値の単純平均値4,285円に対して41.94％"
   },
   "basis": "過去1ヶ月間の終値単純平均値",
   "basis_en": "1-month simple average closing price"
  },
  {
   "value": 45.75,
   "unit": "percent",
   "as_of_date": "2026-01-05",
   "source": {
    "doc_id": "S100XELY",
    "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
    "submitted": "2026-01-07",
    "quote": "同日までの過去３ヶ月間の終値の単純平均値4,173円に対して45.75％"
   },
   "basis": "過去3ヶ月間の終値単純平均値",
   "basis_en": "3-month simple average closing price"
  },
  {
   "value": 45.78,
   "unit": "percent",
   "as_of_date": "2026-01-05",
   "source": {
    "doc_id": "S100XELY",
    "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
    "submitted": "2026-01-07",
    "quote": "同日までの過去６ヶ月間の終値の単純平均値4,172円に対して45.78％"
   },
   "basis": "過去6ヶ月間の終値単純平均値",
   "basis_en": "6-month simple average closing price"
  }
 ],
 "valuations": [
  {
   "valuator": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_as_written": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_en": "Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.",
   "side": "target",
   "method": "comparable",
   "method_label": "類似企業比較分析",
   "method_en": "Comparable companies method",
   "metrics": {
    "per_share_value": {
     "low": 4424,
     "high": 5128,
     "unit": "yen_per_share",
     "source": {
      "doc_id": "S100XELY",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
      "submitted": "2026-01-07",
      "quote": "類似企業比較分析 ：4,424円から5,128円"
     }
    }
   }
  },
  {
   "valuator": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_as_written": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_en": "Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.",
   "side": "target",
   "method": "dcf",
   "method_label": "ＤＣＦ分析",
   "method_en": "DCF method",
   "metrics": {
    "per_share_value": {
     "low": 5578,
     "high": 6570,
     "unit": "yen_per_share",
     "source": {
      "doc_id": "S100XELY",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
      "submitted": "2026-01-07",
      "quote": "ＤＣＦ分析 ：5,578円から6,570円"
     }
    },
    "discount_rate": {
     "low": 5.65,
     "high": 6.65,
     "unit": "percent",
     "source": {
      "doc_id": "S100XELY",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
      "submitted": "2026-01-07",
      "quote": "割引率には加重平均資本コストを採用し、5.65％から6.65％を使用しており"
     }
    }
   }
  },
  {
   "valuator": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_as_written": "三菱UFJモルガン・スタンレー証券株式会社",
   "valuator_en": "Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.",
   "side": "target",
   "method": "market_price",
   "method_label": "市場株価分析",
   "method_en": "Market price method",
   "metrics": {
    "per_share_value": {
     "low": 4172,
     "high": 4500,
     "unit": "yen_per_share",
     "source": {
      "doc_id": "S100XELY",
      "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf",
      "submitted": "2026-01-07",
      "quote": "市場株価分析 ：4,172円から4,500円"
     }
    }
   }
  }
 ],
 "timeline": [
  {
   "date": "2026-01-07",
   "doc_id": "S100XEKS",
   "doc_type_code": "240",
   "doc_type": "公開買付届出書",
   "filer": "タイヨー興産株式会社",
   "filer_en": "Taiyo Kosan Co., Ltd.",
   "description": "公開買付届出書",
   "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XEKS.pdf"
  },
  {
   "date": "2026-01-07",
   "doc_id": "S100XELY",
   "doc_type_code": "290",
   "doc_type": "意見表明報告書",
   "filer": "久光製薬株式会社",
   "filer_en": "HISAMITSU PHARMACEUTICAL CO.,INC.",
   "description": "意見表明報告書",
   "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XELY.pdf"
  },
  {
   "date": "2026-01-14",
   "doc_id": "S100XFSL",
   "doc_type_code": "250",
   "doc_type": "訂正公開買付届出書",
   "filer": "タイヨー興産株式会社",
   "filer_en": "Taiyo Kosan Co., Ltd.",
   "description": "訂正公開買付届出書",
   "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XFSL.pdf"
  },
  {
   "date": "2026-02-03",
   "doc_id": "S100XJ1A",
   "doc_type_code": "250",
   "doc_type": "訂正公開買付届出書",
   "filer": "タイヨー興産株式会社",
   "filer_en": "Taiyo Kosan Co., Ltd.",
   "description": "訂正公開買付届出書",
   "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XJ1A.pdf"
  },
  {
   "date": "2026-02-20",
   "doc_id": "S100XMO3",
   "doc_type_code": "270",
   "doc_type": "公開買付報告書",
   "filer": "タイヨー興産株式会社",
   "filer_en": "Taiyo Kosan Co., Ltd.",
   "description": "公開買付報告書",
   "doc_url": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/pdf/S100XMO3.pdf"
  }
 ],
 "flags": [],
 "unverified_count": 0
}